
Researchers emphasize that while generative AI offers new learning tools for youth, parents must actively supervise its use and prioritize human interaction.

Researchers emphasize that while generative AI offers new learning tools for youth, parents must actively supervise its use and prioritize human interaction.

A study found that AI-generated nutrition plans for adolescents undercalculate caloric needs by an average of 700 kcal and skew macronutrient ratios.

A study found that decreased mortality in children awaiting heart transplants is due to improved overall medical care rather than revisions to waitlist allocation rules.

Children with Crohn disease had reduced microbial diversity and increased proinflammatory bacteria vs peers with disorders of brain-gut interaction.

The approval marks the first treatment option for patients with this rare condition.

Mariana Bueno, PhD, RN, discusses the physiological considerations, clinical barriers, and best practices for effectively using sucrose to mitigate procedural pain in infants.

Universal smartphone use during school, specifically frequent checking, is associated with decreased inhibitory control and attentional resources in teens.

A small dose of sucrose administered before painful hospital procedures is a simple and rapid method for reducing pain in newborns.

Researchers discovered that combining stress management with nutrition education improves parenting behaviors and reduces childhood obesity rates.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

New research demonstrates that moderate to high exercise levels before and during pregnancy can significantly enhance early childhood neurodevelopmental.

New data reveal that implementing rapid diagnostic testing for RSV reduces the rate of unnecessary antibiotic prescriptions for viral respiratory infections.

Clesrovimab has been shown to maintain RSV-protection in infants across 2 RSV seasons, while also having positive safety data.

Clinical trial data demonstrate that clesrovimab maintains a safety profile comparable to palivizumab while providing significant protection against RSV-related infections.

Two recent studies offer insights into the success of nonoperative treatments for pediatric spondylolysis and the potential fracture risks linked to growth hormone therapy.

A study found that drying very preterm infants before immediate plastic wrapping offers no improvement in temperature regulation.

A study found that delivering a small dose of sucrose before painful hospital procedures offers simple and rapid pain reduction for newborns.

A study found that designating a Pediatric Emergency Care Coordinator significantly boosts EMS readiness, care coordination, and safety for young patients.

A study found no significant difference in increased intracranial pressure risk between surgical and conservative management for children with metopic synostosis.

The expanded approval provides young pediatric patients with a proven, effective treatment to significantly reduce dangerously high LDL-C levels.

UCB leadership discusses how bridging regulatory approval and real-world access requires integrated care coordination and a long-term commitment to the patient journey.

Carissa Baker-Smith, MD, MPH, outlines practical office-based interventions to help pediatricians effectively manage youth cardiovascular risk factors.

The approval offers a new genotype-independent treatment option for patients aged 12 years and older, significantly reducing blood phenylalanine levels.

Carissa M. Baker-Smithm MD, MPH, outlines how pediatricians can mitigate long-term cardiovascular risk.

Hao Zhang, PhD, MPH, and Biaskha “Pia” Sen, PHD, discuss factors contributing to the rise in pediatric diabetes rates.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

David Fleischer, MD, discusses how the VITESSE trial positions the VIASKIN peanut patch as a promising option for children with peanut allergy.

Early identification of X-linked hypophosphatemia can prevent long-term skeletal deformities and improve outcomes through timely initiation of targeted therapy.

FDA okays once-weekly navepegritide for children with achondroplasia, boosting growth with strong trial data; rollout expected early Q2 2026.

The FDA has approved once-weekly somapacitan-beco for children aged 2.5 years and older with 3 separate growth indications.